Alveolus alveolus.com


Public lists: Medical Devices (6123)

Alveolus is a developer of non- vascular interventional stent technology. Alveolus' stenting technology enhances the quality of life for patients who suffer from pulmonary or gastrointestinal obstruction. The Alveolus product ideation process allows for rapid prototyping and development of products to address the specific requirements for each area of the body.

Alveolus is a developer of non- vascular interventional stent technology. Alveolus' stenting technology enhances the quality of life for patients who suffer from pulmonary or gastrointestinal obstruction. The Alveolus product ideation process allows ...Show all

Company (Acquired)

Phone:

Fax:

9013 Perimeter Woods
Suite A
Charlotte, 28216
North Carolina, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Alveolus $28M Feb 20, 2009
See all 12 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Alveolus Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 7 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Intella Interventional Systems

Sunnyvale, California, United States
Alive / ActiveStent systems develops angioplasty catheters and guidewires, and related interventional productsLogin to see details

Endologix

Irvine, California, United States
IPO / Went publicEndologix is a developer and manufacturer of minimally invasive treatments for vascular diseases. Endologix is focusing on the development and marketing of its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA). An aneurysm is a weakening of the wall of the aorta, the largest artery of the body. Aortic aneurysm disease is a cause of death in the United States and it is estimated that 1.7 million persons over 55 years of age have an AAA. Each year, physicians diagnose appro...Show allLogin to see details
See all 12 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Removable stent and method of using the same Jul 05, 2002 Jun 16, 2009 Patent
Stent with geometry determinated functionality and method of making the same Nov 05, 2002 May 05, 2009 Patent